Sales decline 12.05% to Rs 4.67 crore
Net Loss of Bharat Immunological & Biological Corporation reported to Rs 2.51 crore in the quarter ended September 2018 as against net loss of Rs 2.39 crore during the previous quarter ended September 2017. Sales declined 12.05% to Rs 4.67 crore in the quarter ended September 2018 as against Rs 5.31 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales4.675.31 -12 OPM %-77.30-44.63 -PBDT-3.60-2.13 -69 PBT-3.70-2.27 -63 NP-2.51-2.39 -5Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)